Clinical Trials
2
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Drug Screening System Method Comparison
- Conditions
- Reagent Kits, Diagnostic
- First Posted Date
- 2024-09-30
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Intelligent Bio Solutions Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT06618183
- Locations
- 🇺🇸
CenExel iResearch, Decatur, Georgia, United States
🇺🇸CenExel HRI, Marlton, New Jersey, United States
PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and Urine
- Conditions
- Pharmacokinetics
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Intelligent Bio Solutions Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06519045
- Locations
- 🇨🇦
Cliantha Research, Mississauga, Ontario, Canada
News
Intelligent Bio Solutions Expands Global Reach with Strategic Partnership in Spain and Andorra
Intelligent Bio Solutions Inc. (INBS) has formed a strategic partnership with Detecto in Spain and Andorra, targeting a drug testing market expected to reach $448 million by 2030.
Intelligent Bio Solutions' Fingerprint Drug Screening System on Track for 2025 FDA Clearance
Intelligent Bio Solutions Inc. has submitted its 510(k) premarket notification to the FDA for its Intelligent Fingerprint Drug Screening System, with clearance expected in 2025 for its opiate test system for codeine.
Intelligent Bio Solutions Secures Sixth U.S. Patent for Fingerprint Drug Screening Technology
Intelligent Bio Solutions Inc. (INBS) has been granted its sixth U.S. patent, strengthening intellectual property protection for its fingerprint sweat-based drug screening technology ahead of planned 2025 U.S. market entry.
Intelligent Bio Solutions Advances Fingerprint Drug Screening Tech Towards FDA Approval
Intelligent Bio Solutions reports positive pharmacokinetic study results, indicating fingerprint sweat accurately reflects codeine levels in blood and saliva.
Intelligent Bio Solutions' Fingerprint Sweat Analysis Shows Promise in Drug Detection
Intelligent Bio Solutions (INBS) reported positive results from its Pharmacokinetic (PK) study, a crucial step toward FDA 510(k) submission.
Intelligent Bio Solutions Progresses in FDA Approval Process for its COVID-19 Testing System
Intelligent Bio Solutions is advancing in the FDA approval process for its rapid COVID-19 testing system, potentially offering a new point-of-care diagnostic tool.